Randomized double-blind placebo controlled crossover trial documenting oral lorcainide efficacy in suppression of symptomatic ventricular tachyarrhythmias
- 1 April 1982
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 103 (4), 511-518
- https://doi.org/10.1016/0002-8703(82)90338-6
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- High-performance liquid chromatographic analysis of lorcainide and its active metabolite, norlorcainide, in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Resistant Ventricular Arrhythmias Treated with Lorcainide, a New Antiarrhythmic DrugChest, 1980
- Lorcainide; II. Plasma concentration‐effect relationshipClinical Pharmacology & Therapeutics, 1979
- Lorcainide; I. Saturable presystemic eliminationClinical Pharmacology & Therapeutics, 1979
- Electrophysiological Actions of Lorcainide in Patients with Cardiac DiseaseJournal of Cardiovascular Pharmacology, 1979
- Lorcainide infusion in the treatment of ventricular premature beats (VPB)European Journal of Clinical Pharmacology, 1979
- Initial clinical experience of lorcainide (Ro 13-1042), a new antiarrhythmic agentEuropean Journal of Clinical Pharmacology, 1978
- Pharmacokinetics of Lorcainide in ManClinical Pharmacokinetics, 1978